These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18798110)

  • 1. Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma.
    Liu X; Hong XN; Gu YJ; Wang BY; Luo ZG; Cao J
    Leuk Lymphoma; 2008 Sep; 49(9):1778-83. PubMed ID: 18798110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal interstitial pneumonitis related to rituximab-containing regimen.
    Herishanu Y; Polliack A; Leider-Trejo L; Grieff Y; Metser U; Naparstek E
    Clin Lymphoma Myeloma; 2006 Mar; 6(5):407-9. PubMed ID: 16640819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab.
    Zhou T; Shen Q; Peng H; Chao T; Zhang L; Huang L; Yang K; Thapa S; Yu S; Jiang Y
    Ann Hematol; 2018 Jan; 97(1):141-147. PubMed ID: 29086009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interstitial pneumonitis as a side effect of rituximab].
    Kemming JL; van Zeeland RE; Ullmann EF; Mattijssen EJ
    Ned Tijdschr Geneeskd; 2009; 153():A526. PubMed ID: 19785875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alveolar hypoxemic interstitial pneumonia related to rituximab therapy].
    Jullien V; Perrin C; Peyrade F; Lemoigne F; Chichmanian RM; Blaive B
    Rev Mal Respir; 2004 Apr; 21(2 Pt 1):407-10. PubMed ID: 15211254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [18F]-fluorodeoxyglucose positron emission tomography combined with computed tomography detection of asymptomatic late pulmonary toxicity in patients with non-Hodgkin lymphoma treated with rituximab-containing chemotherapy.
    Kalkanis D; Stefanovic A; Paes F; Escalon MP; Serafini A; Lossos IS
    Leuk Lymphoma; 2009 Jun; 50(6):904-11. PubMed ID: 19455459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma.
    Katsuya H; Suzumiya J; Sasaki H; Ishitsuka K; Shibata T; Takamatsu Y; Tamura K
    Leuk Lymphoma; 2009 Nov; 50(11):1818-23. PubMed ID: 19863173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
    Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
    Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical analysis of rituximab-induced interstitial lung disease].
    Huang C; Lu ZW; Yang YQ; Chen H; Huang DP; He HS
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Oct; 40(10):730-735. PubMed ID: 29050126
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximab.
    Salmasi G; Li M; Sivabalasundaram V; Panzarella T; Tsang R; Kukreti V; Crump M; Kuruvilla J
    Leuk Lymphoma; 2015 Jun; 56(6):1659-64. PubMed ID: 25356925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two cases of interstitial pneumonitis caused by rituximab therapy.
    Lee Y; Kyung SY; Choi SJ; Bang SM; Jeong SH; Shin DB; Lee JH
    Korean J Intern Med; 2006 Sep; 21(3):183-6. PubMed ID: 17017668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous intravascular large B-cell lymphoma treated with combination chemotherapy and complicated by rituximab-induced interstitial lung disease.
    Park GH; Kim CH; Chung WK; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
    Acta Derm Venereol; 2010 May; 90(3):296-8. PubMed ID: 20526551
    [No Abstract]   [Full Text] [Related]  

  • 13. Rituximab-induced subacute interstitial pneumonitis: a case report and review of literature.
    Subramanian M; Manjunath R; Kilara N; Mohan Rao KN
    J Cancer Res Ther; 2010; 6(3):344-6. PubMed ID: 21119272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rituximab-induced interstitial lung disease].
    Fernández Casares M; Espósito G; González A; Segovia J; Galperín Mde L; Del Valle E
    Medicina (B Aires); 2013; 73(4):343-5. PubMed ID: 23924535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphoma.
    Alexandrescu DT; Dutcher JP; O'Boyle K; Albulak M; Oiseth S; Wiernik PH
    Leuk Lymphoma; 2004 Nov; 45(11):2321-5. PubMed ID: 15512824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab-induced fatal interstitial pneumonitis: case report.
    Vulsteke C; Dierickx D; Verbeken E; Wolter P; Thomas J; Schöffski P
    Leuk Lymphoma; 2010 Mar; 51(3):546-8. PubMed ID: 20038238
    [No Abstract]   [Full Text] [Related]  

  • 17. Rituximab-induced interstitial lung disease.
    Wagner SA; Mehta AC; Laber DA
    Am J Hematol; 2007 Oct; 82(10):916-9. PubMed ID: 17597477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe interstitial pneumonitis following rituximab and bleomycin-containing combination chemotherapy.
    Ghesquieres H
    Ann Oncol; 2005 Aug; 16(8):1399. PubMed ID: 15857843
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial pneumonia after autologous hematopoietic stem cell transplantation in B-cell non-hodgkin lymphoma.
    Kato H; Yamamoto K; Taji H; Oki Y; Chihara D; Seto M; Kagami Y; Morishima Y
    Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):483-9. PubMed ID: 21978956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.